Terry b. Strom

Terry b. Strom's AcademicInfluence.com Rankings

Terry b. Strom

Biology

#5146

World Rank

#7558

Historical Rank

Immunology

#230

World Rank

#239

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Terry b. Strom Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Terry b. Strom's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells (2006) (6954)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression (2007) (2163)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells (2007) (1932)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) (1716)
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. (2000) (951)
IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells (2008) (950)
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. (1997) (861)
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation (2007) (860)
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance (1999) (819)
Mast cells are essential intermediaries in regulatory T-cell tolerance (2006) (759)
Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 (2003) (736)
Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance (2003) (681)
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance (1999) (658)
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance (2003) (609)
B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. (1997) (575)
Cyclosporine: a new immunosuppressive agent for organ transplantation. (1984) (569)
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche (2011) (484)
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. (1986) (442)
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. (1997) (428)
Clinical islet transplantation: advances and immunological challenges (2004) (378)
Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. (1987) (361)
IL-15 and IL-2: a matter of life and death for T cells in vivo (2001) (350)
TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation (2005) (348)
TIM‐3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines (2009) (308)
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content (1983) (308)
A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. (1985) (298)
CD39 and control of cellular immune responses (2007) (289)
Medical progress : renal transplantation (1994) (278)
Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. (2003) (271)
Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells (2007) (268)
Cytokines and the Th1/Th2 paradigm in transplantation. (1994) (251)
Leptin Receptor Expression and Signaling in Lymphocytes: Kinetics During Lymphocyte Activation, Role in Lymphocyte Survival, and Response to High Fat Diet in Mice1 (2006) (250)
T cell death and transplantation tolerance. (2001) (217)
Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. (1987) (211)
IL-2 knockout recipient mice reject islet cell allografts. (1995) (207)
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. (2000) (205)
Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance1 (2002) (201)
CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. (1997) (200)
Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. (1998) (196)
T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. (2009) (193)
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor- mediated action of a diphtheria toxin-related interleukin 2 fusion protein (1988) (191)
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. (2011) (186)
Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. (1995) (180)
Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice (1985) (176)
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. (1999) (174)
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. (1985) (173)
Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells. (1990) (172)
Specific insulin binding site on T and B lymphocytes as a marker of cell activation (1978) (170)
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. (1991) (168)
Identity and cytotoxic capacity of cells infiltrating renal allografts. (1975) (165)
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. (1998) (163)
Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. (1991) (163)
Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. (1984) (162)
Stimulating PD-1–negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival1 (2003) (159)
Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells (2007) (159)
THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITY (1973) (156)
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice (2008) (154)
In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response (2010) (151)
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. (1997) (150)
Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. (1998) (149)
Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. (1993) (141)
Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. (1995) (138)
Targeting IL-15 Receptor-Bearing Cells with an Antagonist Mutant IL-15/Fc Protein Prevents Disease Development and Progression in Murine Collagen-Induced Arthritis1 (2004) (138)
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function (2007) (138)
Immunosuppressants: cellular and molecular mechanisms of action. (1996) (137)
Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease (1992) (133)
Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. (1988) (132)
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. (1972) (131)
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. (1997) (131)
Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. (1996) (130)
Factors contributing to the declining mortality rate in renal transplantation. (1978) (129)
Specificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity1 (2006) (129)
Tim-2 regulates T helper type 2 responses and autoimmunity (2005) (128)
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. (1998) (128)
Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. (1991) (127)
Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. (1990) (127)
Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. (2008) (127)
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs. (2012) (126)
Trends in the use of glucocorticoids in renal transplantation. (1994) (125)
Behaviorally conditioned immunosuppression: replication of a recent study. (1976) (125)
On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. (1998) (124)
Renal transplantation. (1994) (119)
The balance of deletion and regulation in allograft tolerance (2003) (118)
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6 (2009) (117)
Depletion of CD8 Memory T Cells for Induction of Tolerance of a Previously Transplanted Kidney Allograft (2007) (117)
Intragraft IL-15 transcripts are increased in human renal allograft rejection. (1996) (116)
TIM-4 Expressed on APCs Induces T Cell Expansion and Survival1 (2008) (116)
Interleukin 2 receptor‐targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin‐related interleukin 2 fusion protein into cells (1990) (115)
Fibroblast-Like Synoviocytes from Rheumatoid Arthritis Patients Express Functional IL-15 Receptor Complex: Endogenous IL-15 in Autocrine Fashion Enhances Cell Proliferation and Expression of Bcl-xL and Bcl-21 (2002) (115)
Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes. (1974) (115)
Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. (2008) (114)
Critical Role of OX40 in CD28 and CD154-Independent Rejection1 (2004) (114)
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. (1986) (111)
Interleukin 4 inhibits TGF-β-induced-Foxp3+T cells and generates, in combination with TGF-β, Foxp3− effector T cells that produce interleukins 9 and 10 (2008) (108)
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. (1998) (106)
Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. (1977) (106)
LATE MORTALITY AND MORBIDITY IN RECIPIENTS OF LONG‐TERM RENAL ALLOGRAFTS (1982) (106)
Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. (1997) (105)
Exogenous IFN-γ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells (2008) (105)
Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? (1997) (104)
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. (2003) (103)
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement (1976) (102)
Sparing of suppressor cells: a critical action of cyclosporine. (1984) (102)
Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. (1998) (102)
Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. (2011) (101)
Heme oxygenase‐1 modulates the allo‐immune response by promoting activation‐induced cell death of T cells (2005) (100)
THE STRONG CORRELATION OF CYTOTOXIC T LYMPHOCYTE‐SPECIFIC SERINE PROTEASE GENE TRANSCRIPTS WITH RENAL ALLOGRAFT REJECTION1,2 (1992) (100)
Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. (1996) (99)
Liver disease in recipients of long-functioning renal allografts. (1985) (99)
Mechanisms Underlying Blockade of Allograft Acceptance by TLR Ligands1 (2008) (96)
The parallel, time-dependent, bimodal change in lymphocyte cholinergic binding activity and cholinergic influence upon lymphocyte-mediated cytotoxicity after lymphocyte activation. (1981) (94)
Emergence of insulin receptors upon alloimmune T cells in the rat. (1977) (92)
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. (2002) (89)
An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection1 (2001) (88)
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. (1992) (88)
Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma. (1984) (88)
Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells (2014) (86)
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1 (2002) (85)
The role of T cell apoptosis in transplantation tolerance. (2000) (85)
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. (1983) (84)
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. (1992) (84)
SURFACE PROPERTIES AND FUNCTIONAL CHARACTERISTICS OF INFILTRATING CELLS HARVESTED FROM ACUTELY REJECTING CARDIAC ALLOGRAFTS IN INBRED RATS (1975) (83)
Blocking the Common γ-Chain of Cytokine Receptors Induces T Cell Apoptosis and Long-Term Islet Allograft Survival1 (2000) (83)
On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. (2005) (82)
Heritable Susceptibility for Colitis in Mice Induced by IL‐10 Deficiency (2000) (80)
Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. (1997) (79)
Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol (2005) (79)
Insulin-induced augmentation of lymphocyte-mediated cytotoxicity. (1975) (78)
Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. (1979) (77)
Prolonged islet allograft acceptance in the absence of interleukin 4 expression. (1996) (73)
Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations (2009) (73)
Routes to transplant tolerance versus rejection; the role of cytokines. (2004) (72)
The role of cyclic nucleotides in lymphocyte activation and function. (1977) (71)
Acute rejection in vascularized composite allotransplantation (2014) (71)
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts (2007) (71)
Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. (1990) (71)
IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice. (1999) (68)
Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. (1996) (68)
The role of donor and recipient B7-1 (CD80) in allograft rejection. (1997) (68)
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo. (1988) (68)
Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody. (1989) (66)
The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. (1996) (65)
Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection1,2 (2002) (65)
Induction of allograft tolerance in the absence of Fas-mediated apoptosis. (1999) (63)
PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTS (1983) (62)
CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance (2003) (62)
Transplantation biology : cellular and molecular aspects (1996) (62)
5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells. (1995) (62)
Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes (1991) (58)
CYCLOSPORIN A SPARES SELECTIVELY LYMPHOCYTES WITH DONOR‐SPECIFIC SUPPRESSOR CHARACTERISTICS (1981) (58)
Human CD4+ Memory T Cells Can Become CD4+IL-9+ T Cells (2010) (58)
Evidence for Cyclin D3 as a Novel Target of Rapamycin in Human T Lymphocytes* (2004) (57)
DELAYED OMEGA‐3 FATTY ACID SUPPLEMENTS IN RENAL TRANSPLANTATION A DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY (1995) (56)
Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes. (1984) (56)
Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin. (1996) (55)
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine. (1990) (55)
CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN RENAL ALLOGRAFT RECIPIENTS (1984) (55)
Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation‐05 Study (2016) (55)
Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival (2012) (54)
The role of peripheral T-cell deletion in transplantation tolerance. (2001) (54)
Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells. (2012) (54)
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. (1985) (53)
THE EFFECT OF ANTI‐INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY ON ALLOGRAFT REJECTION (1985) (53)
ENHANCEMENT OF IMMUNOSUPPRESSION BY SUBSTITUTION OF FISH OIL FOR OLIVE OIL AS A VEHICLE FOR CYCLOSPORINE (1989) (52)
Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia. (1989) (52)
Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A. (1982) (51)
Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. (1991) (51)
PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL IN MURINE RECIPIENTS TREATED WITH A DIPHTHERIA TOXIN RELATED INTERLEUKIN‐2 FUSION PROTEIN (1989) (50)
Recently discovered T cell subsets cannot keep their commitments. (2009) (50)
Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T‐cell function in transplantation (2007) (49)
Tracking Single Cells in Live Animals Using a Photoconvertible Near-Infrared Cell Membrane Label (2013) (48)
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation. (1989) (47)
Expression of T cell differentiation antigens and Ia on rat cytotoxic T lymphocytes. (1982) (46)
Renal Artery Stenosis in Transplant Patients (1984) (46)
Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. (2002) (46)
Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts. (1993) (45)
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. (1991) (45)
Monoclonal anti-IL-2 receptor antibody in primate renal transplantation. (1987) (45)
Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory. (2014) (44)
Immunosuppressive agents in renal transplantation. (1984) (44)
Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. (1998) (44)
Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. (1979) (44)
Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules. (1994) (43)
Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. (1997) (43)
Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. (1985) (43)
Prolonged Survival of Allogeneic Islets in Cynomolgus Monkeys After Short‐Term Anti‐CD154‐Based Therapy: Nonimmunologic Graft Failure? (2006) (42)
Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope. (1987) (42)
Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allografts. (1976) (42)
Experience with Cyclosporine and Steroids in Clinical Renal Transplantation (1984) (42)
Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction. (1984) (40)
Microtubule Function in Immune and Nonimmune Lymphocyte-Mediated Cytotoxicity (1973) (40)
Prospects and applicability of molecular diagnosis of allograft rejection. (2000) (40)
Secondary hyperparathyroidism in human kidney transplant recipients. (1976) (40)
Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. (2005) (39)
Interleukin 2 receptor targeted fusion toxin (DAB486‐IL‐2) treatment blocks diabetogenic autoimmunity in non‐obese diabetic mice (1992) (39)
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance? (1984) (39)
Leptin Modulates Allograft Survival by Favoring a Th2 and a Regulatory Immune Profile (2013) (38)
Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides. (1975) (38)
Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens. (1986) (37)
Cyclosporine-Induced Nephrotoxicity (1984) (37)
Regulation of T cell dependent immune responses by TIM family members (2005) (36)
Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants. (1997) (36)
An Antagonist Mutant IL-15/Fc Promotes Transplant Tolerance (2006) (35)
Rapamycin induces transforming growth factor-β production by lymphocytes (2000) (35)
Early experience with anti-Tac in clinical renal transplantation. (1989) (35)
Orphan nuclear receptor Nur77 promotes acute kidney injury and renal epithelial apoptosis. (2012) (35)
Interleukin 4 receptor targeted cytotoxicity: Genetic construction and in vivo immunosuppressive activity of a diphtheria toxin‐related murine interleukin 4 fusion protein (1991) (35)
Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. (2001) (34)
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. (1984) (34)
The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression. (2002) (34)
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. (1991) (34)
QUANTITATIVE COMPARISON OF RAPAMYCIN AND CYCLOSPORINE EFFECTS ON CYTOKINE GENE EXPRESSION STUDIED BY REVERSE TRANSCRIPTASE‐COMPETITIVE POLYMERASE CHAIN REACTION1 (1994) (34)
Mechanisms and management of acute renal allograft rejection. (1998) (34)
Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger. (2004) (33)
Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. (1993) (33)
Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. (1986) (33)
ADJUNCTIVE RAPAMYCIN AND CsA TREATMENT INHIBITS MONOCYTE/MACROPHAGE ASSOCIATED CYTOKINES/CHEMOKINES IN SENSITIZED CARDIAC GRAFT RECIPIENTS1 (2001) (33)
Immunofluorescence measurement in a flow cytometer using low-power helium-neon laser excitation. (1983) (32)
Partial mediation of glucocorticoid antiproliferative effects by lipocortins. (1996) (32)
Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells. (1982) (32)
The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. (1999) (32)
Tim-1 Signaling Substitutes for Conventional Signal 1 and Requires Costimulation to Induce T Cell Proliferation1 (2009) (32)
TIM Family Proteins Promote the Lysosomal Degradation of the Nuclear Receptor NUR77 (2012) (32)
The Role of TNF-α in Mice with Type 1- and 2- Diabetes (2012) (31)
Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer (1979) (30)
Monitoring Antidonor Alloantibodies as a Predictive Assay for Renal Allograft Tolerance/Long-term Observations in Nonhuman Primates (2006) (29)
On CD28/CD40 Ligand Costimulation, Common γ-Chain Signals, and the Alloimmune Response1 (2002) (29)
T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates. (1976) (29)
Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples (2019) (29)
Selective immunosuppression with anti‐interleukin 2 receptor‐targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts (1987) (29)
A comparison of the effects of metabolic inhibitors upon direct and antibody-dependent lymphocyte mediated cytotoxicity. (1975) (29)
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine. (2001) (29)
IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival. (1999) (28)
EVIDENCE THAT GLUCOCORTICOSTEROID‐MEDIATED IMMUNOSUPPRESSIVE EFFECTS DO NOT INVOLVE ALTERING SECOND MESSENGER FUNCTION (1991) (28)
MODIFICATION OF THE RAT ALLOIMMUNE RESPONSE BY ENHANCING ANTIBODIES AND THE ROLE OF BLOCKING FACTORS IN THE SURVIVAL OF RENAL GRAFTS (1975) (27)
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF (2015) (27)
Conditioned media from activated lymphocytes maintain sympathetic neurons in culture. (1982) (27)
DEVELOPMENT OF SUPPRESSOR LYMPHOCYTES DURING ACUTE REJECTION OF RAT CARDIAC ALLOGRAFTS AND PRESERVATION OF SUPPRESSION BY ANTI‐IL-2‐RECEPTOR MONOCLONAL ANTIBODY (1986) (27)
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. (1988) (27)
SPECIFICITY OF CELLULAR MIGRATION INTO CARDIAC ALLOGRAFTS IN RATS (1978) (26)
Interleukin-2 (IL-2) induces tyrosine kinase-dependent translocation of active raf-1 from the IL-2 receptor into the cytosol. (1992) (26)
INTERLEUKIN-2 AND INTERFERON-&ggr; DOUBLE KNOCKOUT MICE REJECT HETEROTOPIC CARDIAC ALLOGRAFTS (2000) (26)
Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. (1998) (25)
Electrophysiology of T lymphocyte cholinergic receptors. (1980) (25)
The improving utility of renal transplantation in the management of end-stage renal disease. (1982) (25)
Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation. (1973) (25)
Human serum-free mixed lymphocytes response: the stereospecific effect of insulin and its potentiation by transferrin. (1982) (25)
FUNCTION AND MIGRATION OF SUPPRESSOR LYMPHOCYTES FROM CYCLOSPORINE‐TREATED HEART GRAFT RECIPIENTS (1983) (24)
INTERLEUKIN‐2-DIPHTHERIA TOXIN FUSION PROTEIN PROLONGS MURINE ISLET CELL ENGRAFTMENT (1989) (24)
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. (1987) (24)
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. (1998) (24)
Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones. (1985) (24)
Toward more selective therapies to block undesired immune responses. (1989) (24)
Murine spontaneous T‐cell leukemia constitutively expressing IL‐2 receptor—a model for human T‐cell malignancies expressing IL‐2 receptor (1990) (24)
Immunobiology and immunopharmacology of organ allograft rejection (1995) (23)
Functional Th1 Cells Are Required for Surgical Adhesion Formation in a Murine Model1 (2008) (23)
Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: An open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics (2018) (23)
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. (1991) (23)
Late Mortality and Morbidity in Recipients of Long-Term Renal Allografts (1983) (23)
Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation. (1989) (23)
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection. (1977) (22)
DAB486IL‐2 (IL‐2 Toxin) Selectively Inactivates High‐Affinity IL‐2 Receptor‐Bearing Human Peripheral Blood Mononuclear Cells (1991) (22)
Suppression of in vivo and in vitro alloimmunity by prostaglandins. (1977) (22)
Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation. (2010) (22)
Transcriptional modulation of human IL-6 gene expression by verapamil. (1990) (22)
Adenovirus-mediated beta-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli. (1997) (22)
Antigen-induced unresponsiveness results in altered T cell signaling. (1999) (22)
B7(+)-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. (1994) (21)
Multiparameter flow cytometric analysis of lymphocyte subpopulation activation in lectin-stimulated cultures. (1982) (21)
Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation. (2020) (21)
Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ (2017) (21)
Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. (2000) (21)
Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. (1995) (20)
An IL-2/Ig fusion protein influences CD4+ T lymphocytes in naive and simian immunodeficiency virus-infected Rhesus monkeys. (2001) (20)
RAPAMYCIN INDUCES TRANSFORMING GROWTH FACTOR-&bgr; PRODUCTION BY LYMPHOCYTES1 (2000) (20)
Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptor. (1985) (20)
Interleukin-15 gene transcripts are present in rejecting islet allografts. (1997) (20)
Molecular correlates of human renal allograft rejection. (1998) (20)
Prolongation of organ allograft survival by syngeneic lymphoid cells. (1978) (20)
CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model. (1997) (20)
Augmentation of proliferation and in vitro production of cytotoxic cells by 2-ME in the rat. (1975) (19)
Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy. (1988) (19)
In pursuit of the "holy grail": allograft tolerance. (1994) (19)
Rapid mixed lymphocyte culture testing by analysis of the insulin receptor on alloactivated T lymphocytes: implications for human tissue typing. (1981) (19)
An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation. (1992) (19)
Immunotoxins and Cytokine Toxin Fusion Proteins a (1990) (19)
Cytokine related therapies for autoimmune disease. (2008) (19)
Induce Allograft Tolerance with Combined CTLA 4 Signals Are Required to Optimally (1999) (18)
Prevention of Nonimmunologic Loss of Transplanted Islets in Monkeys (2014) (18)
Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common γ-Chain and CD28/CD154-Dependent and -Independent Mechanisms1 (2003) (18)
Rapid stereospecific stimulation of lymphocytic metabolism by interleukin 2. (1985) (18)
Salutary roles of CD39 in transplantation (2007) (18)
Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones. (1990) (17)
Interleukin‐2 Receptor‐Directed Immunosuppressive Therapies: Antibody‐ or Cytokine‐Based Targeting Molecules (1992) (17)
Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation (1988) (17)
Interleukin-2 apparently upregulates its receptor and induces proliferation of various resting mononuclear leukocytes in the absence of antigen. (1985) (17)
Cerebromeningitis in immunosuppressed recipients of renal allografts. (1982) (17)
Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture. (1983) (16)
CD8+ T Cells Resistant to Costimulatory Blockade Are Controlled by an Antagonist Interleukin-15/Fc Protein (2006) (16)
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody. (1989) (16)
Saving islets from allograft rejection. (2005) (16)
Innate immunity for better or worse govern the allograft response (2015) (16)
Long-term results of cyclosporine treatment in renal transplantation. (1986) (16)
Proteomic Analysis of the Allograft Response (2006) (16)
Dose-related mechanisms of immunosuppression mediated by murine anti-CD3 monoclonal antibody in pancreatic islet cell transplantation and delayed-type hypersensitivity. (1990) (16)
The immunosuppressive effects of verapamil upon mitogen activated and allo-antigen inducible human cytotoxic T-lymphocytes. (1994) (16)
Immunoregulatory drugs: mechanistic basis for use in organ transplantation (1997) (16)
EFFECTS OF THYMECTOMY, THORACIC DUCT DRAINAGE, AND RADIATION ON T AND B LYMPHOCYTE DISTRIBUTION AND CARDIAC ALLOGRAFT SURVIVAL IN RATS (1981) (16)
The role of antibodies in the rejection and enhancement of rat organ allografts: non-Ag-B (Ia) antigens. (1976) (15)
The Role of TNF-\(\alpha\) in Mice with Type 1- and 2- Diabetes (2012) (15)
A longitudinal study of bone disease after successful renal transplantation. (1978) (15)
Rejection--more than the eye can see. (2005) (14)
T cell activation antigens: therapeutic implications. (1987) (14)
Blocking the Common g-Chain of Cytokine Receptors Induces T Cell Apoptosis and Long-Term Islet Allograft Survival (2000) (14)
Therapeutic approach to renal transplantation: triple therapy and beyond. (1988) (14)
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts. (1987) (14)
Stages of T cell activation: continued antigen dependence of IL 2-producing cells after IL 2 receptor expression. (1986) (14)
Pharmacologic and immunologic agonists and antagonists of cyclosporine. (1988) (14)
Short‐term suppression of the xeno‐immune response with mCTLA4‐Fc treatment (1997) (13)
Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model. (2014) (13)
Reply to Failure of combined costimulatory blockade in animal transplant model (2000) (13)
Transcriptional profiling to assess the clinical status of kidney transplants (2006) (13)
Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine. (2002) (13)
Rapamycin Generates Graft-Homing Murine Suppressor CD8+ T Cells That Confer Donor-Specific Graft Protection (2011) (13)
A close relationship between cytotoxic T lymphocytes generated in the mixed lymphocyte culture and insulin receptor-bearing lymphocytes: enrichment by density gradient centrifugation. (1979) (13)
Immunologic enhancement of rat renal allografts. III. Immunopathologic lesions and rejection in long-surviving passively enhanced grafts. (1975) (13)
Clinical and experimental aspects of renal allograft rejection. (1981) (12)
Case 15-1986: Renal Disorder 13 Months after Renal Transplantation for the Hemolytic Uremic Syndrome (1986) (12)
Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts. (1991) (12)
Regulation of T-Cell Immunity by T-Cell Immunoglobulin and Mucin Domain Proteins (2007) (12)
Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts. (1997) (12)
Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys. (1977) (12)
Humoral and cellular mechanisms in acute allograft injury. (1987) (12)
Restricted TCR V beta repertoire in the human mixed lymphocyte reaction is determined by the TCR on the responder cell and not by the stimulating antigen on the stimulator cell. (1996) (11)
Transplantation: immunogenetic and clinical aspects--Part I. (1982) (11)
Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates. (2012) (11)
Passive enhancement of rat renal allografts by antibodies to a non-SD (Ag-B) locus analogous to Ia and demonstration of linkage to the MHC. (1977) (11)
Blocking T‐cell costimulation in transplantation: opportunities and challenges (2000) (11)
Use of intragraft gene expression in the diagnosis of kidney allograft rejection. (1996) (11)
Hepatitis B, transfusions and renal transplantation. (1977) (11)
A kinetic analysis of the effects of interleukin-2 diphtheria toxin fusion protein upon activated T cells. (1990) (11)
The Relationship between Early T Cell Activation Antigens and T Cell Proliferation (1983) (11)
A RANDOMIZED, PROSPECTIVE, MULTICENTER TRIAL OF T‐CELL ANTIBODY INDUCTION THERAPY IN PEDIATRIC RENAL TRANSPLANTATION.: Abstract# 1 (2000) (10)
T-cell growth factors in allograft rejection and tolerance. (1999) (10)
Is transplantation tolerable? (2004) (10)
Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. (1995) (10)
Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment. (1998) (10)
On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response. (2002) (10)
Posttransplant immunologic monitoring of the renal allograft recipient. (1978) (10)
Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade. (2002) (10)
The cascading, interrelated roles of interleukin-1, interleukin-2, and interleukin-6 in murine anti-CD3-driven T cell proliferation. (1990) (10)
The potential role of xenogeneic antigen‐presenting cells in T‐cell co‐stimulation (1996) (10)
Monoclonal anti-T12 antibody as therapy for renal allograft rejection. (1983) (10)
The Absence of Cryptic Insulin Receptors on Resting Lymphocytes (1981) (10)
Correction: Tracking Single Cells in Live Animals Using a Photoconvertible Near-Infrared Cell Membrane Label (2013) (9)
2006 Homer W. Smith Lecture: taming T cells. (2007) (9)
SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOBIOLOGICAL MANIPULATIONS IN RAT HEART GRAFT RECIPIENTS1 (1988) (9)
Immunological tolerance and liver transplantation. (2004) (9)
Regulatory role of the cyclic nucleotides in alloimmune lymphocyte mediated cytotoxicity. Effect of imidazole. (1973) (9)
IL-2 DEPENDENT RAPAMYCIN RESISTENT SIGNALS ARE REQUIRED FOR TOLERANCE INDUCTION AND T CELL APOPTOSIS (1998) (9)
Contrasting Roles of Islet Resident Immunoregulatory Macrophages and Dendritic Cells in Experimental Autoimmune Type 1 Diabetes (2016) (9)
Elevated Intracellular cAMP Levels Inhibit Interleukin-1 Production by the Tumour Cell Line U937 (1985) (9)
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine. (1983) (9)
Inability of autoimmune mice with the lpr gene to spontaneously produce interleukin 3 (1986) (9)
Editorial retrospective: hepatitis B, transfusions, and renal transplantation -- five years later. (1982) (9)
Interleukin-2 Fusion Protein (DAB389IL- 2) Selectively Targets Activated Human Peripheral Blood and Lamina Propria Lymphocytes (1997) (9)
The early (18-hr) human mixed lymphocyte reaction: identification and isolation of activated T-cell clones. (1985) (8)
Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance. (2006) (8)
Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital. (1985) (8)
MIGRATION PATTERNS OF LYMPHOCYTES IN UNTREATED AND IMMUNOLOGICALLY MANIPULATED RECIPIENTS OF ORGAN ALLOGRAFTS (1982) (8)
The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction. (1991) (8)
Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction. (1990) (8)
A magic bullet for cancer--how near and how far? (2001) (8)
The cellular and molecular basis of allograft rejection: what do we know? (1988) (8)
Cellular immunity in the mouse. 3. In vitro kinetic studies on the relationship between recognition and effector phases. (1973) (8)
In Memoriam: Charles Bernard Carpenter (2012) (8)
Donor‐strain‐derived immature dendritic cell pre‐treatment induced hyporesponsiveness against allogeneic antigens (2010) (8)
In primed allo‐tolerance, TIM‐3‐Ig rapidly suppresses TGFβ, but has no immediate effect on Foxp3 (2008) (8)
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat. (1985) (8)
Identification, cytotoxicity, and suppressor activity of infiltrating cells from enhanced organ allografts. (1977) (8)
Interleukin 2 toxin: a step toward selective immunomodulation. (1988) (8)
Immunoglobulin-cytokine fusion molecules: the new generation of immunomodulating agents. (1998) (8)
A20--a biomarker of allograft outcome: a showcase in kidney transplantation. (2014) (7)
DIFFERENTIAL ANTIBODY RESPONSES TO Ag‐B (A REGION) AND Ia (B REGION) ANTIGENS DURING ENHANCEMENT OF RAT RENAL ALLOGRAFTS1 (1979) (7)
T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation. (2010) (7)
Hematopoietic Stem/Progenitor Cell Dependent Participation of Innate Lymphoid Cells in Low-Intensity Sterile Inflammation (2018) (7)
Mechanisms of cardiac allograft prolongation by cyclosporin-A. (1981) (7)
Cytokines in the treatment and prevention of autoimmune responses-a role of IL-15. (2003) (7)
Detection of anti-donor "Ia" antibodies: a strong correlate of rejection. (1978) (7)
SIMILAR EFFECTS OF CYCLOSPORINE AND VERAPAMIL ON LYMPHOKINE, INTERLEUKIN 2 RECEPTOR, AND PROTO‐ONCOGENE EXPRESSION (1989) (7)
Delayed-Type Hypersensitivity 2 a Protein Blocks γ IL-15 Mutant / Fc Targeting the IL-15 Receptor with an Antagonist (1998) (7)
REJECTION AND ENHANCEMENT IN AN IN VITRO MODEL OF ALLOIMMUNITY: Comparison of F1 and Parental Strains (1973) (7)
Regulation of transplantation tolerance by T-cell growth factors (2000) (7)
The effects of varying dialysis regimens on lymphocyte stimulation. (1975) (7)
Interleukin 2 receptor--a target for immunosuppressive therapy. (1987) (7)
T-cell growth factors and the allograft response (2003) (7)
Immunotherapy using interleukin-2 diphtheria toxin chimer prolongs murine allografts. (1989) (7)
IL-2 and IL-4 double knock-out mice reject islet allografts: a role for novel T-cell growth factors? (1997) (7)
Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. (1987) (7)
DIFFERENTIAL EFFECT OF GAMMA‐IRRADIATED AND HEAT‐TREATED LYMPHOCYTES ON T CELL ACTIVATION, AND INTERLEUKIN‐2 AND INTERLEUKIN‐3 RELEASE IN THE HUMAN MIXED LYMPHOCYTE REACTION (1987) (7)
Liver Disease in Recipients of Long-Functioning Renal Allografts (1986) (6)
Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation. (2011) (6)
Interleukin-2 Receptor Directed Immunosuppressive Therapy (1987) (6)
Cyclosporin A plus fish oil: accentuate the positive, eliminate the negative. (1989) (6)
TIM-1: A New Player in Transplant Immunity (2009) (6)
Antibody valence and induced signal transduction: the role of antibody valence in anti-CD3-induced signal transduction in isolated normal T cells. (1989) (6)
Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome (1989) (6)
Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: modulation by PGE1 and dietary lipid. (1992) (6)
Cyclosporin-induced nephrotoxicity. Inevitable and intractable? (1984) (6)
Therapeutic approach to organ transplantation. (1996) (6)
Bone Marrow–Derived Hematopoietic Stem and Progenitor Cells Infiltrate Allogeneic and Syngeneic Transplants (2014) (6)
Intragraft immune events causing vascularized organ graft rejection. (1978) (6)
Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity. (1988) (6)
Successful pancreas-renal transplantation without anti-T-cell antibody induction. (1995) (6)
Posttransplant Recurrent FSGS: Molecular Insights and Future Directions (1999) (6)
Stability of renal allograft recipients after conversion from cyclosporine to azathioprine. (1985) (6)
Genetically engineered proteins for immunoregulation. (1995) (5)
Immunotoxins and cytokine toxin fusion proteins. (1990) (5)
LONG‐TERM RENAL ALLOGRAFT SURVIVAL IN RATS PREIMMUNIZED WITH DONOR STRAIN RT1.B ANTIGENS (1983) (5)
RESTORATION OF ALLOGRAFT RESPONSIVENESS IN B RATS (1983) (5)
Interleukin2 Receptor-mediated Action of a DiphtheriaToxin-related Interleukin2 Fusion Protein (1988) (5)
Enhanced Intramucosal Cytotoxic Lymphocyte Gene Expression in Ulcerative Colitis (1995) (5)
Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens. (1978) (5)
CTL effector mechanisms: diagnostic applications. (1998) (5)
A characterization of the nature and control of cellular allograft rejection. (1978) (5)
ANTIBODY‐DEPENDENT LYMPHOCYTE‐MEDIATED CYTOTOXICITY (Ab‐LMC), DEFINITION OF THE “K CELL” IN THE RAT (1976) (5)
Prolongation of primate renal allografts with anti-Tac monoclonal antibody. (1988) (5)
Interleukin 2 counteracts the inhibition of cytotoxic T lymphocytes by cholera toxin in vitro and in vivo (1991) (5)
On the identity of lymphoid cells that stimulate the rat MLC and produce active enhancement. (1977) (5)
A rare find – cells that improve bone marrow transplantation (2000) (5)
Differential regulation of activation-associated receptor expression on CD4- and CD8-positive T lymphocytes by allosensitized suppressor T cells. (1989) (5)
Creating transplant tolerance by taming adverse intragraft innate immunity (2010) (5)
Verapamil selectively inhibits expression of interleukin-2 messenger RNA in mitogen activated mononuclear blood cells. (1989) (5)
Studies on mechanisms of acute rejection of vascularized organ allografts. (1986) (5)
Protein Engineering of DAB‐IL‐2 Fusion Toxins to Increase Biologic Potency a (1991) (5)
Cyclosporine in Renal Transplantation (1984) (5)
Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins. (1987) (4)
Interleukin-7 (IL-7) and its effect on the expression of the intercellular adhesion molecule (ICAM-1) in T cells. (1991) (4)
Transfer of specific unresponsiveness to organ allografts by thymocytes. (1999) (4)
Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein. (1988) (4)
The role of a primate model of renal transplantation in the development of new monoclonal antibodies. (1989) (4)
Therapeutic strategies using monoclonal antibodies in autoimmune disease. (1989) (4)
Hand transplants and the mandate for tolerance (2014) (4)
Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4. (1992) (4)
Regulation of Alloimmunity by Cyclic Nucleotides (1977) (4)
Comparison of ligand-specific rat allosensitized lymphocyte insulin receptors as assessed in binding and functional (lymphocyte-mediated cytotoxicity) assays. (1980) (4)
Can childhood viral infection protect from type 1 diabetes? (2009) (4)
Inhibition of human antigen-specific memory B cell response in vitro by a diphtheria toxin-related interleukin 2 fusion protein. (1991) (4)
Increased Expression with Interferon-'y (1984) (4)
Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human disease. (1992) (4)
Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4. (1996) (4)
THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON (1973) (4)
Transplant rejection and paradigms lost. (2013) (4)
Absence of a role for the cellular exoskeleton in the emergence of the T lymphocyte insulin receptor. (1979) (4)
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deployment. (2004) (4)
Prolonged islet allograft acceptance in the absence of expression of interleukin-4. (1997) (4)
Modulation of gvh proliferation by cyclic nucleotides. (1975) (4)
The Effects of Antithymocyte Globulin in NZB-NZW F1 Mice∗ (1968) (3)
New approaches in tolerance induction (2001) (3)
Intoxication of high affinity IL-2 receptor positive thymocytes blocks early stages of T cell maturation. (1992) (3)
Molecular characterization and functional activity of an IL-15 antagonist MutIL-15/Fc human fusion protein. (2013) (3)
Anti-Interleukin-2 Receptor Monoclonal Antibody Treatment Prolongs Allograft Survival (1986) (3)
INCREASED INTRAGRAFT ANGIOTENSINOGEN GENE EXPRESSION IN POST-TRANSPLANT RECURRENT FSGS (1998) (3)
Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy. (1981) (3)
Interleukin-2 receptor signal transduction: translocation of active serine-threonine kinase Raf-1 from IL-2 receptor into cytosol depends on IL-2-induced tyrosine kinase activation. (1993) (3)
IN VITRO MODULATION OF PHYTOHEMAGGLUTININ-P INDUCED BLASTOGENESIS BY PARATHYROID HORMONE (1977) (3)
Spleen cell factor inhibits lymphoproliferation, abnormal Ia expression and overt autoimmunity in MRL-lpr mice. (1986) (3)
Suppression of renal allograft rejection by low density thymocytes. (1981) (3)
BLOCKING OF T CELL ACTIVATION AT THE G1A/G1B INTERFACE OF THE CELL CYCLE AND PREVENTION OF EXPRESSION OF INTERLEUKIN 2 RECEPTORS BY ALLOACTIVATED SUPPRESSOR T LYMPHOCYTES (1988) (3)
Multiple organ-reactive IgG antibody induced by an antiidiotypic antibody to a human monoclonal IgM autoantibody (1986) (3)
TARGETING THE IL-15 RECEPTOR WITH AN ANTAGONIST IL-15/Fc??2a PROTEIN BLOCKS DTH AND ENHANCES THE ACCEPTANCE OF ISLET ALLOGRAFTS (1998) (3)
Phorbol myristate acetate-protein complex mimics bioactivity of human IL-1. 1. Direct evidence that PMA temporarily enters and is released from cellular compartment during superinduction protocol. (1985) (3)
Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice. (1989) (3)
Sa.15. The TIM-3 and its Ligand Mediated Signaling Negatively Regulates T Helper Type 1 Immunity (2006) (3)
Tolerance--is it worth it? (2014) (3)
Treatment with anti-interleukin-2 receptor monoclonal antibody. (1986) (3)
The role of novel T‐cell growth factors in rejection (1997) (3)
RAPAMYCIN INDUCES TGF-β PRODUCTION IN LYMPOCYTES (1999) (3)
Current stage of interleukin 2 receptor targeted therapy. (2009) (3)
Death of alloreactive T cells sets the stage for immunoregulation to act. (2001) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Type 2 diabetes : questions and answers (2003) (2)
B-cell alloantigen matching by the lymphocyte insulin receptor assay. (1981) (2)
Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc. (1973) (2)
Natural killer cell response to interferons. (1986) (2)
Bidirectional modulation of gene expression by interleukin 6 cyclosporine and corticosteroids (1990) (2)
"Free-market" approach to organ donation. (1984) (2)
Human renal allograft rejection: Immune mechanisms, molecular correlates and treatment strategies (1996) (2)
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic. (1989) (2)
Renal Allograft Rupture: A Strategy for Graft Preservation (2011) (2)
A Signature of Gene Expression in Peripheral Blood that Enables Earlier Detection of Acute Rejection in Kidney Transplant Recipients (2018) (2)
ORGAN-SPECIFIC T-CELL GROWTH FACTOR AND CTL GENE ACTIVATION IN RENAL AND LIVER TRANSPLANT REJECTION (1999) (2)
Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A. (1988) (2)
[The immunobiology of transplant rejection and its pharmacological modification]. (2008) (2)
Functional Th 1 Cells Are Required for Surgical Adhesion Formation in a Murine Model 1 (2008) (2)
Choosing Rational Combinations Of Therapeutic Agents: Contrasting Effects Of Costimulation Blockade Plus Rapamycin Or Cyclosporin On Intragraft Expression Of Chemokines, Chemokine Receptors And Apoptotic Genes. (1999) (2)
Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys. (1989) (2)
T-helper 1 and T-helper 2 paradigm in the acquisition of peripheral graft tolerance (2000) (2)
Transplantation - Editorial overview (1994) (2)
Improving the efficacy of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator (2018) (2)
Lymphocyte subsets in heart allograft rejection in a rat model: effect of in vitro generated suppressor cells. (1981) (2)
MLR-reactive thymocytes in the rat: Ia-positive stimulator and Ia-negative responder cells. (1979) (2)
Cyclic nucleotides in immunosuppression--neuroendocrine pharmacologic manipulation and in vivo immunoregulation of immunity acting via second messenger systems. (1980) (2)
Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection. (2005) (2)
Summary: Today's Biotechnology and Tomorrow's Antirejection Therapy (1988) (2)
Cyclosporine in renal transplantation: a review of clinical and experimental studies (1987) (1)
Adenovirus-Mediated PD-L1 Over-Expression Has Differential Effects on Allograft Survival in Murine Islet and Heart Transplant Models. (2004) (1)
CHARACTERIZATION OF THE ADHERENT SPLENIC SUPPRESSOR CELLS (1977) (1)
Immunosuppressive therapy for renal transplantation (2005) (1)
IN VITRO STIMULATION OF UNPRIMED LYMPHOCYTES BY ALLOGENEIC SEMI-SOLUBLE LYMPHOCYTE MEMBRANE FRAGMENTS (1977) (1)
Abstract (Part 1 of 4) (1993) (1)
Decreased Expression of Human Class 11 Antigens on Monocytes from Patients with Acquired Immune Deficiency Syndrome (2013) (1)
Quantitative competitive polymerase chain reaction: design and synthesis of mRNA-specific competitor DNA templates and their clinical usage. (1998) (1)
Activity on Serum AmyloidA Synthesis andT-Lymphocyte Activation (1988) (1)
BLOCK THE COMMON γ CHAIN OF CYTOKINE RECEPTORS INDUCES PERMANENT ALLOGRAFT TOLERANCE (1999) (1)
Immunological properties of subcellular rat lymphocyte preparations. Primary allogeneic stimulation in vitro by fractions containing Ia (RT1- B), but not RT1-A antigens (1980) (1)
Regulation of the Alloimmune Response (2012) (1)
Transplantation: immunogenetic and clinical aspects--part II. (1983) (1)
Abstract (Part 2 of 4) (1993) (1)
Modulation of Cytotoxic T Lymphocyte Function by Cyclic 3′,5′-Mononucleotides (1974) (1)
Sequential analysis by polymerase chain reaction of mononuclear leukocyte activation-associated transcription in pancreatic islet cell allograft rejection. (1991) (1)
CD8+ DEPENDENT ALLOGRAFT REJECTION IS RESISTANT TO CONVENTIONAL COSTIMULATION BLOCKADE: EMERGING THERAPIES.: Abstract# 1153 (2000) (1)
Use of a reperfusion catheter after angioplasty dissection for salvage of ischemic renal allograft: Case report (1991) (1)
Kidney transplantation in the treatment of terminal uremia. (1981) (1)
The Improving Utility of Renal Transplantation in the Management of End-Stage Renal Disease (1983) (1)
Suppressor cells in enhancement of organ allografts. (1979) (1)
PRESENCE OF SPLENIC SUPPRESSOR CELLS IN ALLOGRAFT ENHANCED RATS (1977) (1)
Response to High Fat Diet in Mice Activation, Role in Lymphocyte Survival, and Lymphocytes: Kinetics During Lymphocyte Leptin Receptor Expression and Signaling in (2006) (1)
Populations of infiltrating cells removed from rejecting rat cardiac allografts. (1974) (1)
Interleukin-2 Receptor Targeted Immunosuppressive Therapy with Anti-Interleukin-2 Receptor Monoclonal Antibodies Directed against the L-Chain of the Interleukin-2 Receptor: Studies on Selectivity and Mode of Action (1989) (1)
SIGNALS TRANSDUCED BY THE COMMON γ CHAIN OF CYTOKINE RECEPTORS ARE CRITICAL IN ALLOGRAFT REJECTION (1998) (1)
Proceedings: Nature of cells removed from rejecting rat cardiac allografts;. (1975) (1)
T cells and their products in host responsiveness to organ allografts. (1986) (1)
34: Hematopoietic Stem/Progenitor Cell Dependent Participation of Innate Lymphoid Cells in Low-Intensity Sterile Inflammation (2019) (1)
IL-2 + INTERFERON-γ DOUBLE KNOCKOUT MICE REJECT HETEROTOPIC CARDIAC ALLOGRAFTS. (1998) (1)
OR.57. IL-4 Inhibits TGF-β-induced Foxp3+T Cells and, Together with TGF-β, Generates IL-9+IL-10+Foxp3-Effector T Cells (2009) (1)
INTRARENAL EXPRESSION OF CYTOTOXIC ATTACK MOLECULES DURING ACUTE REJECTION OF RENAL ALLOGRAFTS IN PEDIATRIC RECIPIENTS (1998) (1)
HLA-D activity in lymphocyte subcellular fractions. (1978) (1)
A paradigm 1994: the allograft response. (1995) (1)
Modification of the mixed lymphocyte reaction by alloactivated suppressor T lymphocytes and exogenous interleukin-2. (1987) (1)
RAPAMYCIN SYNERGIZES WITH DST PLUS ANTI-CD154 TO BLOCK AUTO AND ALLO-IMMUNE RESPONSE AND INDUCE ISLET ALLOGRAFT ENGRAFTMENT IN SPONTANEOUS AUTOIMMUNE DIABETIC NOD RECIPIENTS (1999) (0)
Interleukin-15 antagonists (1997) (0)
CD154-Independent Rejection Critical Role of OX40 in CD28 and (2010) (0)
2-Me in the Rat Vitro Production of Cytotoxic Cells by Augmentation of Proliferation and in (2010) (0)
A High Throughput Molecular Assay for Detection of Renal Graft Acute Cellular Rejection Using Peripheral Blood (2012) (0)
COMBINED TREATMENT WITH AN IL‐15 MUTANT /Fc PROTEIN AND CTLA4/Fc ALLOWS PERMANENT ENGRAFTMENT.: Abstract# 1155 (2000) (0)
Alloreactive T Cell Clone Size Cells, and the + CTLA-4, CD25 Regulating Alloimmunity: Cytokines, Physiological Mechanisms of (2010) (0)
CD 28 / CD 154-Dependent and-Independent-Chain and γ Mice Involves the Common Islet Allograft Rejection in Nonobese Diabetic (2003) (0)
DOMINANT T CELL REGULATION ACHIEVED EX-VIVO VIA IFN-GAMMA/STAT-1 SIGNALING AND NITRIC OXIDE INDUCTION: 19 (2008) (0)
Gene-Expression Profiles of Peripheral Blood Cells and of Allograft Biopsies Are Associated With Acute Rejection in Pediatric Renal Allograft Recipients.: Abstract# C1528 (2014) (0)
54 INDUCTION OF TOLERANCE TO A FOREIGN ANTIGEN IL-2 RECEPTOR-BINDING SUBSTANCES ( 75 ) Inventors : (0)
Diphtheria Toxin-Related Peptide Hormone Fusion Proteins: New Toxins with Therapeutic Potential (1992) (0)
Glutamine 108 is critical for interleukin 15 (IL-15) function in peripheral blood mononuclear cells and intestinal epithelial cells (1998) (0)
Breaking immune tolerance to prostate-associated tumor antigens through Tim-1 receptor (162.20) (2012) (0)
THE PRECISE ROLE OF CD28 AND CD154 POSITIVE AND CTLA4 NEGATIVE SIGNALS IN THE ALLOGRAFT RESPONSE.: Abstract# 1158 (2000) (0)
Syngeneic Lymphoic Cells Prolongation of Organ Allograft Survival by (2012) (0)
[Fever and changes in renal function after kidney and pancreas transplant in a 22-year-old diabetic woman]. (1989) (0)
Diff erential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and eff ector function (2007) (0)
Rapid detection of mixed lymphocyte culture reactivity by 4F2 antigen appearance as detected by flow cytometry (1982) (0)
Alpha-1 Antitrypsin improves engraftment in a rat model of hepatocyte transplantation through inhibition of the innate immune system (2017) (0)
EXPRESSION OF IL-2 RECEPTOR α β AND γ SUBUNITS BY ACTIVATED T CELLS IS REGULATED BY CELL CYCLE.: Abstract# 527 Poster Board #-Session: P167-II (2000) (0)
Sequential expression of CD39 regulates late developmental T helper type 17 plasticity imparting a regulatory cell phenotype (2013) (0)
Tolerance induction for islet transplantation in stringent models. (2003) (0)
Altered T Cell Signaling Antigen-Induced Unresponsiveness Results in Burakoff (1999) (0)
Extramural Grant Program Meeting (Part 1 of 4) (1993) (0)
A SHORT-TERM TREATMENT WITH A COMBINATION OF IL-2/Fc AND MUTANT IL-15/Fc FUSION PROTEINS PROLONGED ISLET GRAFT SURVIVAL IN DIABETIC CYNOMOLGUS MONKEYS (2004) (0)
ARALAST or ANTI-TNF-a TREATMENT PREVENTS AUTOIMMUNE DESTRUCTION OF ISLET GRAFTS IN NONOBESE DIABETIC (NOD) MICE (131.23) (2007) (0)
Ligands de tim-3 et methodes associees (2004) (0)
Plasmid Cytokine/Ig Administration Responses to an HIV-1 DNA Vaccine by Augmentation and Suppression of Immune (1998) (0)
In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents. (1992) (0)
Novel Immunotherapeutic Proteins: Immunoligand (2007) (0)
Subject Index Vol. 82, 1999 (1999) (0)
Fast Track On the Intraoperative Molecular Status of Renal Allografts after Vascular Reperfusion and Clinical Outcomes (2005) (0)
Modulation of T cell responses mediated by IL-2 and IL15. (2001) (0)
Abstract (Part 4 of 4) (1993) (0)
Immunological Monitoring and Renal Transplantation (1984) (0)
ALLOANTIGEN-UNRESPONSIVENESS IS ASSOCIATED WITH EARLY TCR SIGNALING DEFECTS IN VIVO (1998) (0)
Extramural Grant Program (Part 3 of 5) (1995) (0)
A major regulatory role of local NKG2D ligand expression in transplantation (2012) (0)
Th1→Th2 IMMUNE DEVIATION FACILITATES, BUT DOES NOT CARSE TOLERANCE (1999) (0)
Transplantation: A new molecular approach to the diagnosis of acute rejection (2013) (0)
2013 British Transplant Society Annual Congress (2013) (0)
Myelin specific regulatory T cells expand from naturally occurring regulatory T cells and accumulate in the CNS during EAE (128.8) (2007) (0)
Function in Alloimmunity Regulatory T Cell + CD25+ Specificity of CD4 (0)
IL-4 IS REQUIRED FOR TOLERANCE INDUCTION INDUCED BY DEPLETING ANTI-CD4 mAb (1999) (0)
Alloimmune Response -Chain Signals, and the g Common On CD28/CD40 Ligand Costimulation, (2002) (0)
Book ReviewLymphocytes and Their Cell Membranes. (1976) (0)
OVERCOMING T CELL MEMORY FOR INDUCTION OF DELAYED RENAL ALLOGRAFT TOLERANCE IN NONHUMAN PRIMATES: 895 (2010) (0)
Administration Vaccine by Plasmid Cytokine/Ig Immune Responses to an HIV-1 DNA Augmentation and Suppression of (2010) (0)
IL‐15 REGULATES FAS MEDIATED APOPTOSIS.: Abstract# 525 Poster Board #‐Session: P165‐II (2000) (0)
In vitro generation of suppressor lymphocytes with subcellular membrane fragments. (1981) (0)
Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ (2017) (0)
IL-21 ALTERS IMMUNE REGULATION AND PROMOTES TH17 IN ALLORESPONSE: 644 (2008) (0)
Continuous density gradient separation of allosensitized cells from a mixed lymphocyte culture. (1981) (0)
Summation of the biologic aspects of the congress. (1993) (0)
UPREGULATION OF A20, AN ANTI‐APOPTOTIC GENE, IS ASSOCIATED WITH HUMAN RENAL ALLOGRAFT REJECTION.: Abstract# 1037 (2000) (0)
Proceedings/Optimization of immunosuppressive therapy while minimizing infection in renal transplantation striking a balance, symposium, Boca Raton, FL, USA, March 25-26, 1988 (1988) (0)
THE POWERFUL T-CELL TOLERIZING CONSEQUENCES OF BLOCKING EXPRESSION OF PRO-, NOT ANTI-INFLAMMATORY MECHANISM: 297 (2008) (0)
MRL-lpr mice metabolites, and suppresses lupus in acid reduces cyclooxygenase A fish oil diet rich in eicosapentaenoic (2010) (0)
INHIBITION OF Fc RECEPTORS, MLC, AND RAT RENAL ALLOGRAFT REJECTION BY ALLO-ANTISERA LACKING ANTI-Ag-B SEROLOGICAL SPECIFICITY (1976) (0)
Adenosine Diphosphate Ribosylation of Elongation Factor-2 as a Therapeutic Target: Genetic Construction and Selective Action of a Diphtheria Toxin-Related Interleukin-2 Fusion Protein (1989) (0)
The Anti-Inflammatory Effect of Alpha-1 Antitrypsin in Hepatocyte Transplantation (2018) (0)
A Quantitative Evaluation of Immune Activation Cytokine Gene Transcripts in Renal AllograftBiopsies 1842 (1998) (0)
IN VIVO TIME-LAPSE IMAGING OF NAΪVE T CELLS CONVERSION TO REGULATORY T CELLS IN ALLOGRAFT ISLET TRANSPLANTATION: 738 (2008) (0)
Extramural Grant Program (Part 1 of 5) (1995) (0)
Extramural Grant Program (Part 5 of 5) (1995) (0)
A Patient with Post‐Hepatitis B Immune Deficiency: Nonspecific Helper Factor Partially Restores the in vitro Immune Response 1 (1981) (0)
CD 154-Independent Rejection Critical Role of OX 40 in CD 28 and Sayegh and (2004) (0)
Induction of transplantation tolerance permitting stable engraftment of allografts without life-long immunosuppression (2001) (0)
A refined understanding of immunosuppressives and cancer risk. (2003) (0)
Alloreactive T Cell Clone Size + Alloimmunity : Cytokines , CTLA-4 , CD 25 Physiological Mechanisms of Regulating (2002) (0)
Leukaemia Inhibitory Factor (LIF) is a Treg cytokine (141.35) (2009) (0)
Nature of the Allograft Responses Th2 Immune Deviation, and the On Histocompatibility Barriers, Th1 to (2010) (0)
Targeting the IL-2 receptor with antibodies or chimeric toxins (2001) (0)
IL-10 fusion protein reduces pulmonary ICAM-1 expression and injury in diet induced pancreatitis in mice (2001) (0)
Evidence of Tissue Growth Factor Beta TGF-β1 - Induced Sclerosis in the Glomeruli of Children with Focal Segmental Glomerulosclerosis (FSGS)• 1843 (1998) (0)
Tissue growth factor beta -induced sclerosis in the glomeruli of children with FSGS (1998) (0)
Nanobiomedicine Multiple Sclerosis and the LIF / IL-6 Axis : Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF Invited Review Article (2015) (0)
CD 4 + CD 25 + regulatory T cells in transplantation tolerance (0)
Extramural Grant Program Meeting (Part 3 of 4) (1993) (0)
The immunopharmacology of graft rejection. (1987) (0)
2014 British Transplant Society Conference (2014) (0)
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation. (1987) (0)
Extramural Grant Program (Part 2 of 5) (1995) (0)
Requirements for primary T cell activation. (1987) (0)
Immunogenetics and transplantation. (2010) (0)
Absence of Fas-Mediated Apoptosis Induction of Allograft Tolerance in the (1999) (0)
5 – Receptor-Specific Intoxication of Tumor Cells: Design, Construction, and Properties of Microbial: Toxin–Growth Factor Fusion Proteins (1991) (0)
Studies on living cells harvested from acutely rejecting and enhanced rat cardiac allografts. (1975) (0)
Molecular diagnosis: a bridge to individualized care for the transplant recipient (2006) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Tim-4 Expressed on Antigen-presenting Cells Induces T Cell Expansion and Survival (2007) (0)
De Novo Expression of Receptors on T Cells (1988) (0)
CD4+ CD25+ regulatory T cells mediate antigen-specificity in a novel TCR transgenic model of alloimmunity (2005) (0)
Contents Vol. 82, 1999 (1999) (0)
Extramural Grant Program Meeting (Part 2 of 4) (1993) (0)
Non-Invasive Tests to Help Stratify Risk of Rejection in Renal Transplant Recipients. (2014) (0)
INCREASED INTRAGRAFT EXPRESSION OF ACTIVATED CYTOTOXIC LYMPHOCYTE GENES IN REJECTING HUMAN CARDIAC ALLOGRAFTS.: Abstract# 38 (2000) (0)
Correction (2005) (0)
CONCURRENT SESSION 46: TRANSLATIONAL STUDIES IN NON-HUMAN PRIMATES (2006) (0)
Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components. (1987) (0)
Toward More Selective Therapies to Block Autoimmunity (2019) (0)
DIFFERENTIAL EFFECTS OF CYCLOSPORINE AND RAPAMYCIN ON COSTIMULATION BLOCKADE INDUCED ALLOGRAFT TOLERANCE: INTRAGRAFT CTL GENE EXPRESSION ANALYSIS (1999) (0)
Ligands Allograft Acceptance by TLR Mechanisms Underlying Blockade of (2010) (0)
A Multiplatform Biomarker Signature Of Acute Rejection In Renal Allograft Recipients (2014) (0)
INCREASED TREG STABILITY UPON GRAFT TOLERANCE INDUCTION IN LYMPHOPENIC HOSTS: 185 (2010) (0)
“LESS IS MORE”: APC WITH WEAKER CO-STIMULATORY ACTIVITIES SUPPORT BETTER CONVERSION OF NAÏVE T CELLS (2006) (0)
The insulin receptor: a marker of T cell activation after allograft. (1976) (0)
Costimulation Blockade-Resistant Rejection An Antagonist IL-15 / Fc Protein Prevents (2001) (0)
CHAPTER 11 – INTERLEUKIN 2 RECEPTOR-DIRECTED IMMUNOSUPPRESSIVE THERAPY (1988) (0)
Rapid murine mixed lymphocyte cultures assessed by emergence of T-cell insulin receptors. (1978) (0)
OR.38. Following Interaction with TIM-4, Regulatory T Cells Lack Immunoregulatory Function (2008) (0)
Induction of alloreactivity. (1983) (0)
CONCURRENT SESSION 4: GENERATION AND FUNCTION OF TREGS (2006) (0)
Messenger RNA Levels in Peripheral Blood and Urine Can Potentially Stratify Risk of Rejection Following Renal Transplantation: 1583 (2012) (0)
THE COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) IMMUNE EFFECOR MECHANISM CONTRIBUTES TO MR1 ANTI‐CD154 INDUCED IMMUNOSUPPRESSION.: Abstract# 303 Poster Board #‐Session: P150‐I (2000) (0)
2014 British Transplant Society Conference (Oral) (2014) (0)
THE INSULIN RECEPTOR ON THE T CELL: A MARKER OF ACTIVATION AFTER STIMULATION (1977) (0)
2012 The 3rd International Conference on Transplantomics and Biomarkers in Organ Transplantation (2012) (0)
ROLE OF RAT LYMPHOCYTE SUBPOPULATIONS IN THE MIXED LYMPHOCYTE CULTURE (MLC) (1977) (0)
Reciprocal generation of Treg and Th1/Th17 cells by conventional B cells and B1 B cells (88.46) (2007) (0)
Signal 1 and Requires Costimulation to Tim-1 Signaling Substitutes for Conventional (2009) (0)
DIAGNOSTIC ACCURACY OF CYTOTOXIC LYMPHOCYTE (CL) GENE EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES (PBL): CORRELATION WITH REJECTING RENAL ALLOGRAFTS (1998) (0)
Arthritis Progression in Murine Collagen-Induced Prevents Disease Development and an Antagonist Mutant IL-15 / Fc Protein Targeting IL-15 Receptor-Bearing Cells with Strom and (2004) (0)
2012 British Transplant Society 15TH ANNUAL CONGRESS (2012) (0)
ISLET ALLOGRAFT SURVIVAL IN DIABETIC MONKEYS AFTER ANTI-CD154, DST, AND DELAYED REPAMYCIN TREATMENT (2004) (0)
Erratum: IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ Foxp3− effector T cells (2009) (0)
BLOCKING OX40 COSTIMULATION OR MTOR IS REQUIRED TO PREVENT CD8+ MEDIATED REJECTION (2004) (0)
Proliferationto Induce T Cell Conventional Signal 1 and Requires Tim-1 Signaling Substitutes for (2010) (0)
Purines 2008 Meeting 29 June – 2 July 2008, Copenhagen, Denmark (2008) (0)
Rapid murine mixed lymphocyte cultures assessed by emergence of T-cell insulin receptors (1978) (0)
Correction: Figure 5. (2005) (0)
Using anti-il-12 antibodies in transplantationsabstossungen (1998) (0)
Extramural Grant Program (Part 4 of 5) (1995) (0)
Effects of an Agonist IL-2/Fc Fusion Protein, A Mutant Antagonist IL-15Fc Fusion Protein and Sirolimus on Cardiac Allograft Survival in Non-Human Primates (2013) (0)
Analysis of the subpopulations of T blasts bearing insulin receptors obtained by 1-g velocity sedimentation of murine mixed lymphocyte cultures. (1979) (0)
SPECIFICITY AND FUNCTION OF CD4+ CD25+ REGULATORY T CELLS IN A NOVEL CD4+ TCR-TRANSGENIC MODEL OF ALLOIMMUNITY (2004) (0)
Extramural Grant Program Meeting (Part 4 of 4) (1993) (0)
A major regulatory role of NKG2D ligands in transplantation (2011) (0)
Methods of evaluation of replacement of transplantation. (1998) (0)
Sequence-specific targeting on the interleukin-2 receptor P55 chain gene expression by antisense oligonucleotides (1995) (0)
Sequential expression of CD39 regulates late developmental Th17 plasticity imparting a regulatory cell phenotype (179.20) (2012) (0)
Messenger RNA Levels in Non-Invasive Samples Can Potentially Stratify Risk of Rejection in Renal Transplant Recipients (2013) (0)
PASSIVE T CELL DEATH IS NOT REQUIRED FOR INDUCTION OF TRANSPLANTATION TOLERANCE TO MINOR HISTOCOMPATIBILITY ANTIGENS MISMATCHED ALLOGRAFTS.: Abstract# 134 (2000) (0)
ignorance or proliferation (1994) (0)
EXPRESSION OF IL‐2 RECEPTOR &agr; &bgr; AND &ggr; SUBUNITS BY ACTIVATED T CELLS IS REGULATED BY CELL CYCLE.: Abstract# 527 Poster Board #‐Session: P167‐II (2000) (0)
Bcl-2 LBcl-x Enhances Cell Proliferation and Expression of Endogenous IL-15 in Autocrine Fashion Functional IL-15 Receptor Complex : Rheumatoid Arthritis Patients Express Fibroblast-Like Synoviocytes from Wlodzimierz (2002) (0)
Monoclonal Antibody Treatment Transfusion and Anti-CD154 with Combined Donor-Specific Optimally Induce Allograft Tolerance CTLA4 Signals Are Required to (2010) (0)
THE ROLE OF IL-21 ANTAGONIZING FUSION PROTEIN IN TRANSPLANTATION (2004) (0)
Endogenous IL-15 in autocrine fashion enhances rheumatoid arthritis fibroblast-like synoviocytes proliferation and resistance to apoptosis (2002) (0)
RejectionGrowth Factors in Allograft T Reject Islet Allografts: A Role for Novel IL-2 and IL-4 Double Knockout Mice (2010) (0)
Abstract (Part 3 of 4) (1993) (0)
Active During Allograft Tolerance Tracking the Immunoregulatory Mechanisms (2002) (0)
Curriculum vitae of John P. Merrill (1978) (0)
Using a Nonlymphoablative Irradiation-Free Mixed Chimerism and Allograft Tolerance Roles of Deletion and Regulation in Creating (2005) (0)
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules. (1993) (0)
Allograft Acceptance by TLR Ligands Mechanisms Underlying Blockade of (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Terry b. Strom?

Terry b. Strom is affiliated with the following schools:

University of Western Ontario

Terry b. Strom's Academic­Influence.com Rankings

Why Is Terry b. Strom Influential?

Terry b. Strom's Published Works

Published Works

What Schools Are Affiliated With Terry b. Strom?

Terry b. Strom's AcademicInfluence.com Rankings